The Programme in Cancer and Stem Cell Biology (CSCB) is one of five founding Signature Research Programmes of the Duke-NUS Medical School. CSCB has a broad scope of research. Our faculty engage in hypothesis-driven basic science and disease-oriented investigation, as well as active drug discovery and innovative clinical trials. We are committed to translation of key findings, and our faculty have moved basic science discoveries from bench to bedside, with clinical trials in multiple cancers driven by discoveries made by CSCB scientists.

Back
Saturday, 10 Oct, 2020

Dr Vaidehi Krishnan wins John Goldman Award 2020

CONGRATULATIONS to Dr Vaidehi Krishnan from Duke-NUS' Cancer & Stem Cell Biology Signature Research Programme for winning the John Goldman Award 2020.

Vaidehi's award

Dr Krishnan received the award for her proposed work on interrogating diagnostic chronic myeloid leukaemia bone marrow samples using the latest single-cell approaches, and identifying patients who will have durable treatment-free responses. By integrating the results of the analyses with established clinical workflows, her study aims to develop a test that can reliably predict the outcome of tyrosine kinase inhibitor therapy discontinuation.

Error.

An error occurred while processing your request.